[
    {
        "kind": "youtube#video",
        "etag": "M0dD3FuwACw507EUhxIrd5NryqM",
        "id": "D_HQYf8fAQ8",
        "snippet": {
            "publishedAt": "2021-09-29T23:08:44Z",
            "channelId": "UCl6LnwGSOSoSFAHuIKWZIXQ",
            "title": "Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes",
            "description": "APSC Journal Club Series\nHot Topics in Cardiology\nRole of SGLT 2 in HFpEF and Its Impact on Renal Outcomes\nCo-organised by APSC Emerging Leaders\n29 September 2021, Wednesday 1800-1900 hours Singapore Time (UTC +8)\n\nChair:\nClin A/Prof Jack Tan\nDeputy Head & Senior Consultant \nDepartment of Cardiology, National Heart Centre Singapore \nSenior Consultant \nNHCS Cardiology @ SKH Sengkang General Hospital \nPresident, Asian Pacific Society of Cardiology\nPresident, International Society of Cardiovascular Pharmacotherapy\n\nCo-chair:\nClin A/Prof Jonathan Yap\nConsultant\nDepartment of Cardiology\nNational Heart Centre Singapore\n\nPresenters & Topics:\nDr James Xu \nConsultant\nLiverpool Hospital\nSydney, Australia\nTopic: EMPEROR-Preserved\n\nDr Chien Do Van\nDeputy Head of Department \n108 Military Hospital\nVietnam\nTopic: EMPEROR-Pooled \n\nModerators:\nProf Andrew Coats\nDirector\nMonash Warwick Alliance\nAcademic Vice-President\nMonash and Warwick Universities, UK\nAustralia\n\nProf David Sim\nSenior Consultant\nDepartment of Cardiology\nNational Heart Centre Singapore\n\nEndorsed by:\nInternational Society of Cardiovascular Pharmacotherapy\nSingapore Cardiac Society\n\nIn collaboration with: \nBoehringer Ingelheim",
            "thumbnails": {
                "default": {
                    "url": "https://i.ytimg.com/vi/D_HQYf8fAQ8/default.jpg",
                    "width": 120,
                    "height": 90
                },
                "medium": {
                    "url": "https://i.ytimg.com/vi/D_HQYf8fAQ8/mqdefault.jpg",
                    "width": 320,
                    "height": 180
                },
                "high": {
                    "url": "https://i.ytimg.com/vi/D_HQYf8fAQ8/hqdefault.jpg",
                    "width": 480,
                    "height": 360
                },
                "standard": {
                    "url": "https://i.ytimg.com/vi/D_HQYf8fAQ8/sddefault.jpg",
                    "width": 640,
                    "height": 480
                },
                "maxres": {
                    "url": "https://i.ytimg.com/vi/D_HQYf8fAQ8/maxresdefault.jpg",
                    "width": 1280,
                    "height": 720
                }
            },
            "channelTitle": "APSC Asian Pacific Society of Cardiology",
            "tags": [
                "APSC",
                "SGLT2i",
                "Emperor Preserved"
            ],
            "categoryId": "27",
            "liveBroadcastContent": "none",
            "localized": {
                "title": "Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes",
                "description": "APSC Journal Club Series\nHot Topics in Cardiology\nRole of SGLT 2 in HFpEF and Its Impact on Renal Outcomes\nCo-organised by APSC Emerging Leaders\n29 September 2021, Wednesday 1800-1900 hours Singapore Time (UTC +8)\n\nChair:\nClin A/Prof Jack Tan\nDeputy Head & Senior Consultant \nDepartment of Cardiology, National Heart Centre Singapore \nSenior Consultant \nNHCS Cardiology @ SKH Sengkang General Hospital \nPresident, Asian Pacific Society of Cardiology\nPresident, International Society of Cardiovascular Pharmacotherapy\n\nCo-chair:\nClin A/Prof Jonathan Yap\nConsultant\nDepartment of Cardiology\nNational Heart Centre Singapore\n\nPresenters & Topics:\nDr James Xu \nConsultant\nLiverpool Hospital\nSydney, Australia\nTopic: EMPEROR-Preserved\n\nDr Chien Do Van\nDeputy Head of Department \n108 Military Hospital\nVietnam\nTopic: EMPEROR-Pooled \n\nModerators:\nProf Andrew Coats\nDirector\nMonash Warwick Alliance\nAcademic Vice-President\nMonash and Warwick Universities, UK\nAustralia\n\nProf David Sim\nSenior Consultant\nDepartment of Cardiology\nNational Heart Centre Singapore\n\nEndorsed by:\nInternational Society of Cardiovascular Pharmacotherapy\nSingapore Cardiac Society\n\nIn collaboration with: \nBoehringer Ingelheim"
            },
            "defaultAudioLanguage": "en"
        },
        "contentDetails": {
            "duration": "PT1H3M44S",
            "dimension": "2d",
            "definition": "hd",
            "caption": "false",
            "licensedContent": false,
            "contentRating": {},
            "projection": "rectangular"
        },
        "status": {
            "uploadStatus": "processed",
            "privacyStatus": "public",
            "license": "youtube",
            "embeddable": true,
            "publicStatsViewable": true,
            "madeForKids": false
        },
        "statistics": {
            "viewCount": "368",
            "likeCount": "11",
            "dislikeCount": "0",
            "favoriteCount": "0",
            "commentCount": "1"
        }
    }
]